Sign In
Buy NXTC
$3.15
-0.250 (-7.35%)
At Close: Jun 03, 2026
Hedge Funds Have Never Been This Bullish On NextCure, Inc. (NXTC)
04:28pm, Wednesday, 15'th Apr 2020
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was
NextCure (NXTC) Gets a Buy Rating from Morgan Stanley
03:36pm, Wednesday, 15'th Apr 2020
Morgan Stanley analyst Jeffrey Hung maintained a Buy rating on NextCure (NXTC) today and set a price target of $58.00. The company's shares closed last
Alnylam's Blackstone Funding, And Other News: The Good, Bad And Ugly Of Biopharma
10:10pm, Tuesday, 14'th Apr 2020
Alnylam received $2bn funding from Blackstone. NextCure postpones trial launch due to coronavirus. Fennec Pharmaceuticals' NDA is accepted by the FDA.
Needham Keeps a Buy Rating on NextCure (NXTC)
02:15pm, Monday, 13'th Apr 2020
Needham analyst Chad Messer reiterated a Buy rating on NextCure (NXTC) today and set a price target of $72.00. The company's shares closed last Monday at
Needham Keeps a Buy Rating on NextCure (NXTC)
02:15pm, Monday, 13'th Apr 2020
Needham analyst Chad Messer reiterated a Buy rating on NextCure (NXTC – Research Report) today and set a price target
NextCure Provides Update on Clinical Trial Activities Due to Impact of COVID-19 Pandemic
11:05am, Monday, 13'th Apr 2020
NextCure, Inc. (NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases, today
NextCure to Present at the 19th Annual Needham Virtual Healthcare Conference
11:05am, Wednesday, 08'th Apr 2020
NextCure, Inc. (NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases, today
Macquarie Group Ltd. Invests $5.63 Million in NextCure Inc (NASDAQ:NXTC)
11:04am, Wednesday, 08'th Apr 2020
Macquarie Group Ltd. purchased a new position in shares of NextCure Inc (NASDAQ:NXTC) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Com
NextCure Inc (NASDAQ:NXTC) Receives Consensus Rating of "Buy" from Brokerages
09:42am, Wednesday, 08'th Apr 2020
Shares of NextCure Inc (NASDAQ:NXTC) have received an average recommendation of “Buy” from the ten brokerages that are presently covering the firm, MarketBeat.com reports. One research analyst has
Sofinnova Investments Strengthens Executive Team with Promotions of Maha Katabi, PhD, CFA and Sarah Bhagat, PhD
01:00pm, Tuesday, 31'st Mar 2020
Sofinnova Investments announces the promotions of Maha Katabi and Sarah Bhagat.
NextCure appoints Garry Nicholson to board of directors NXTC;GTHX
11:52am, Monday, 30'th Mar 2020
NextCure appoints Garry Nicholson to board of directors NXTC GTHX
NextCure Announces Appointment of Veteran Oncology Executive Garry Nicholson to its Board of Directors
11:05am, Monday, 30'th Mar 2020
NextCure, Inc. (NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases, today
Alliancebernstein L.P. Has $59.89 Million Stock Holdings in NextCure Inc (NASDAQ:NXTC)
08:56am, Monday, 30'th Mar 2020
Alliancebernstein L.P. boosted its holdings in shares of NextCure Inc (NASDAQ:NXTC) by 86.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and
Critical Comparison: Sarepta Therapeutics (NASDAQ:SRPT) versus NextCure (NASDAQ:NXTC)
05:44am, Sunday, 29'th Mar 2020
Sarepta Therapeutics (NASDAQ:SRPT) and NextCure (NASDAQ:NXTC) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuat
Why You Shouldn't Bet Against NextCure (NXTC) Stock
12:52pm, Thursday, 26'th Mar 2020
NextCure (NXTC) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well
